Please use this identifier to cite or link to this item:
|Title:||Pharmacokinetic and pharmacodynamic effects of a single nocturnal dose of alprazolam.|
|Authors:||Norman, Trevor R;Burrows, Graham D;McIntyre, I M|
|Affiliation:||Department of Psychiatry, University of Melbourne, Austin Hospital, Heidelberg, Victoria, Australia.|
|Citation:||International Clinical Psychopharmacology; 5(2): 111-7|
|Abstract:||Six healthy volunteers participated in a study of the pharmacokinetic and psychomotor effects of a single dose of 2 mg of alprazolam compared to placebo when given at night. Alprazolam reached a maximum concentration in the plasma between 0.5 and 2.5 h after the dose. It was extensively distributed to the tissues as shown by the large apparent volume of distribution (1.42 l/kg) and slowly eliminated (t1/2 = 13.7 h). Significant impairment of choice reaction time occurred 1 and 11 h after the dose of alprazolam compared to placebo. Critical flicker fusion was also impaired after alprazolam but the difference from the placebo administration did not reach significance.|
|Internal ID Number:||2199575|
Alprazolam.administration & dosage.pharmacokinetics
Drug Administration Schedule
Flicker Fusion.drug effects
Randomized Controlled Trials as Topic
Sensory Thresholds.drug effects
|Appears in Collections:||Journal articles|
Files in This Item:
There are no files associated with this item.
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.